On Tuesday, iKang Healthcare Group Inc (ADR) (NASDAQ:KANG)’s shares inclined 4.16% to $17.51.
iKang Healthcare Group, Inc. (KANG), China’s largest private preventive healthcare services provider, recently declared that it has formed a joint venture (“Joint Venture”) with former shareholders of Yinchuan Ciming Clinic Co., Ltd. (“Yinchuan Ciming” or “Yinchuan Ciming Medical Center”). Yinchuan Ciming was franchised from Ciming Checkup Group, the third largest private preventive healthcare services provider in China. iKang now owns 70% equity in the Joint Venture, which itself controls 100% ownership of Yinchuan Ciming. Yinchuan Ciming is the largest private preventive healthcare services provider in Yinchuan and has been renamed to Yinchuan iKang. Yinchuan is the capital city of Ningxia Hui Autonomous Region in China.
This acquisition has particular planned significance for iKang as it will act as a beacon to attract more high-quality Ciming franchises to join iKang. Yinchuan Ciming Medical Center ranked among the top Ciming franchises in 2014 in terms of revenue. In November 2014, iKang attained three medical centers that were franchised from Ciming Checkup Group in the city of Shenyang. This acquisition marks the second time that a Ciming franchisee has turned down Ciming Checkup Group and others in favour of iKang.
iKang Healthcare Group, Inc., together with its auxiliaries, provides preventive healthcare solutions in the People’s Republic of China. The company offers a range of medical examinations, which comprise internal, gynecology, ophthalmology, ENT, dental, lab tests, electrocardiogram, ultrasound, and X-ray examination items.
ServiceNow Inc (NYSE:NOW)’s shares gained 1.06% to $77.41.
ServiceNow (NOW), the enterprise cloud company, recently declared it will release financial results for the second quarter 2015 ended June 30, 2015 following the close of market on Wednesday, July 29, 2015. ServiceNow will host a conference call and live webcast to talk about the financial results.
ServiceNow, Inc. provides cloud-based solutions that define, structure, manage, and automate services to enterprise operations in North America, Europe, the Middle East, Africa, the Asia Pacific, and other countries. The company offers service administration solutions, counting incident administration, problem administration, change administration, request administration, and cost administration, in addition to service catalog and knowledge base; and IT, HR, facilities, and field service administration solutions.
At the end of Tuesday’s trade, Celsion Corporation (NASDAQ:CLSN)‘s shares surged 3.45% to $2.40.
Celsion Corporation (CLSN) declared positive interim data from its ongoing open-label Phase 2 DIGNITY Trial of ThermoDox® in recurrent chest wall (RCW) breast cancer. The trial is designed to enroll up to 20 patients at several U.S. clinical sites and is evaluating ThermoDox in combination with mild hyperthermia. Of the 17 patients enrolled and treated, 13 were eligible for evaluation of efficacy. Based on data accessible to date, every patient practiced a clinical benefit of their highly refractory disease within the ThermoDox treatment field, with a local response rate of 69% observed in the 13 evaluable patients, notably five complete responses (CR), four partial responses (PR) and four patients with stable disease (SD). The Company will complete enrollment in the study in the third quarter of 2015.
Celsion Corporation, an oncology drug development company, focuses on the development and commercialization of chemotherapeutic oncology drugs based on its proprietary heat-activated liposomal technology. The company’s lead product comprises ThermoDox, a liposomal encapsulation of doxorubicin that is in Phase III clinical trials for primary liver cancer; and under Phase II clinical trials for recurrent chest wall breast cancer.
HORSEHEAD HOLDING CORP. (NASDAQ:ZINC), ended its Tuesday’s trading session with 2.36% gain, and closed at $9.56.
Horsehead Holding Corp. (ZINC), declared that its wholly owned direct and indirect auxiliaries, INMETCO, Horsehead Corporation and Horsehead Metal Products, LLC, reached a new secured revolving credit facility with Macquarie Bank Limited, maturing on May 15, 2017. The new facility replaces the maximum aggregate $80 million principal amount of two credit facilities to which these auxiliaries formerly were parties. It is in the same maximum principal amount, and is secured by the same collateral of such auxiliaries. However, the new credit facility accommodates a broader borrowing base than such previous credit facilities, adding about $30 million of additional availability.
Horsehead Holding Corp., together with its auxiliaries, produces and sells zinc and nickel-based products primarily in the United States and Canada. The company operates through three segments: Horsehead, Zochem, and INMETCO. The Horsehead segment processes electric arc furnace dust and other zinc-bearing material to produce and sell zinc and other metals.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
